Moxifloxacin Stulln (Moxifloxacin)

Moxifloxacin is a fluoroquinolone antibiotic used to manage bacterial infections of the eye.

• Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of redness and discharge.
• Keratitis: eradicates causative bacteria, helping to preserve corneal integrity and visual acuity.
• Other ocular bacterial infections: provides broad‑spectrum coverage for Gram‑positive and Gram‑negative pathogens affecting the ocular surface.

• Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to these targets, it prevents bacterial DNA supercoiling and separation, leading to inhibition of bacterial cell division and ultimately bacterial cell death. This bactericidal action is effective against a wide range of Gram‑positive and Gram‑negative ocular pathogens.

Moxifloxacin ophthalmic solution may cause local and systemic reactions, although many patients tolerate it well.

Common Side Effects

• Eye irritation or burning sensation.
• Redness of the conjunctiva.
• Temporary blurred vision.
• Tearing or increased lacrimation.
• Mild headache.
• Dry eye sensation.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis) with swelling, rash or difficulty breathing.
• Corneal ulceration or perforation.
• Persistent or worsening eye pain.
• Vision loss.
• Tendon rupture (systemic exposure).
• Central nervous system effects such as seizures (rare).

Before using Moxifloxacin ophthalmic solution, consider the following safety measures.

• Allergy assessment: avoid if known hypersensitivity to fluoroquinolones.
• Contact lens use: remove lenses before instillation and wait before reinserting.
• Pregnancy and lactation: consult a healthcare professional; safety data are limited.
• Concomitant ocular disease: use with caution in patients with corneal epithelial defects.
• Systemic fluoroquinolone exposure: monitor for tendon or CNS adverse events.
• Store below 25°C: keep in the original container, protect from light and moisture.

Moxifloxacin ophthalmic solution can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Systemic fluoroquinolones: concurrent use may increase risk of tendon rupture.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): may heighten risk of corneal complications.

Moderate Interactions (Monitor Closely)

• Antacids or supplements containing aluminum, magnesium, calcium, or iron: can reduce systemic absorption if taken orally.
• Corticosteroid eye drops: may mask signs of infection.
• Warfarin: potential for enhanced anticoagulant effect with systemic exposure.